Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells

Published:2016-09 Issue: Volume:38 Page:460-467
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Ye Jun-feng,Lin Yuan-qiang,Yu Xiu-hua,Liu Ming-yuan,Li Yang

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Jilin University

Jilin Province Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference33 articles.

1. Synergistic interaction of telomerase-specific oncolytic virotherapy and chemotherapeutic agents for human cancer;Fujiwara;Curr. Pharm. Biotechnol.,2012

2. Manipulating immune cells for adoptive immunotherapy of cancer;Darcy;Curr. Opin. Immunol.,2014

3. Adoptive cell transfer therapy;Dudley;Semin. Oncol.,2007

4. Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know;Rosenberg;Nat Rev Clin Oncol.,2011

5. Adoptive T, cell therapy for cancer in the clinic;June;J. Clin. Invest.,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner;Biomarker Research;2024-03-25

2. Hydrogel-based co-delivery of CIK cells and oncolytic adenovirus armed with IL12 and IL15 for cancer immunotherapy;Biomedicine & Pharmacotherapy;2022-07

3. Combination of oncolytic adenovirus ZD55 harboring TRAIL-IETD-MnSOD and cytokine-induced killer cells against lung cancer;Annals of Translational Medicine;2021-10

4. CCR7 as a therapeutic target in Cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-01

5. Oncolytic Adenovirus in Cancer Immunotherapy;Cancers;2020-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3